Literature DB >> 23772309

An Amino-Benzosuberene Analogue That Inhibits Tubulin Assembly and Demonstrates Remarkable Cytotoxicity.

Rajendra P Tanpure1, Clinton S George, Madhavi Sriram, Tracy E Strecker, Justin K Tidmore, Ernest Hamel, Amanda K Charlton-Sevcik, David J Chaplin, Mary Lynn Trawick, Kevin G Pinney.   

Abstract

The recent discovery of a small-molecule benzosuberene-based phenol that demonstrates remarkable picomolar cytotoxicity against selected human cancer cell lines and strongly inhibits tubulin polymerization (1-2 µM) inspired the design and synthesis of a variety of new, structurally diverse benzosuberene derivatives. An efficient synthetic route to functionalized benzosuberenes was developed. This methodology utilized a Wittig reaction, followed by a selective alkene reduction and ring-closing cyclization to form the core benzosuberone structure. This synthetic route facilitated the preparation of a 6-nitro-1-(3',4',5'-trimethoxyphenyl) benzosuberene derivative and its corresponding 6-amino analogue in good yield. The 6-amino analogue was a strong inhibitor of tubulin polymerization (1.2 µM), demonstrated enhanced cytotoxicity against the human cancer cell lines examined (GI50 = 33 pM against SK-OV-3 ovarian cancer, for example), and exhibited a concentration dependent disruption of a pre-established capillary-like network of tubules formed from human umbilical vein endothelial cells.

Entities:  

Year:  2012        PMID: 23772309      PMCID: PMC3682772          DOI: 10.1039/C2MD00318J

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  25 in total

1.  Synthesis and biological evaluation of aryl azide derivatives of combretastatin A-4 as molecular probes for tubulin.

Authors:  K G Pinney; M P Mejia; V M Villalobos; B E Rosenquist; G R Pettit; P Verdier-Pinard; E Hamel
Journal:  Bioorg Med Chem       Date:  2000-10       Impact factor: 3.641

Review 2.  The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents.

Authors:  Dietmar W Siemann
Journal:  Cancer Treat Rev       Date:  2010-06-08       Impact factor: 12.111

3.  Synthesis of benzocycloheptanones through coupling of δ,ε-unsaturated chromium carbene complexes and 2-alkynylbenzoyl derivatives.

Authors:  Rajesh Kumar Patti; Kristopher V Waynant; James W Herndon
Journal:  Org Lett       Date:  2011-05-09       Impact factor: 6.005

4.  Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agents.

Authors:  Keith A Monk; Rogelio Siles; Mallinath B Hadimani; Benon E Mugabe; J Freeland Ackley; Scott W Studerus; Klaus Edvardsen; Mary Lynn Trawick; Charles M Garner; Monte R Rhodes; George R Pettit; Kevin G Pinney
Journal:  Bioorg Med Chem       Date:  2006-01-25       Impact factor: 3.641

5.  Regio- and stereospecific synthesis of mono-beta-d-glucuronic acid derivatives of combretastatin A-1.

Authors:  Rajendra P Tanpure; Tracy E Strecker; David J Chaplin; Bronwyn G Siim; Mary Lynn Trawick; Kevin G Pinney
Journal:  J Nat Prod       Date:  2010-06-25       Impact factor: 4.050

Review 6.  Differentiation and definition of vascular-targeted therapies.

Authors:  Dietmar W Siemann; Michael C Bibby; Graham G Dark; Adam P Dicker; Ferry A L M Eskens; Michael R Horsman; Dieter Marmé; Patricia M Lorusso
Journal:  Clin Cancer Res       Date:  2005-01-15       Impact factor: 12.531

7.  The tumor vascular targeting agent combretastatin A-4-phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cells.

Authors:  Chryso Kanthou; Gillian M Tozer
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

Review 8.  A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P).

Authors:  Dietmar W Siemann; David J Chaplin; Patricia A Walicke
Journal:  Expert Opin Investig Drugs       Date:  2009-02       Impact factor: 6.206

9.  Isolation, structure, and synthesis of combretastatins A-1 and B-1, potent new inhibitors of microtubule assembly, derived from Combretum caffrum.

Authors:  G R Pettit; S B Singh; M L Niven; E Hamel; J M Schmidt
Journal:  J Nat Prod       Date:  1987 Jan-Feb       Impact factor: 4.050

10.  Design, synthesis and biological evaluation of dihydronaphthalene and benzosuberene analogs of the combretastatins as inhibitors of tubulin polymerization in cancer chemotherapy.

Authors:  Madhavi Sriram; John J Hall; Nathan C Grohmann; Tracy E Strecker; Taylor Wootton; Andreas Franken; Mary Lynn Trawick; Kevin G Pinney
Journal:  Bioorg Med Chem       Date:  2008-07-24       Impact factor: 3.641

View more
  8 in total

1.  Synthesis and biological evaluation of structurally diverse α-conformationally restricted chalcones and related analogues.

Authors:  Casey J Maguire; Graham J Carlson; Jacob W Ford; Tracy E Strecker; Ernest Hamel; Mary Lynn Trawick; Kevin G Pinney
Journal:  Medchemcomm       Date:  2019-06-04       Impact factor: 3.597

2.  Synthesis and Biological Evaluation of Benzocyclooctene-based and Indene-based Anticancer Agents that Function as Inhibitors of Tubulin Polymerization.

Authors:  Christine A Herdman; Tracy E Strecker; Rajendra P Tanpure; Zhi Chen; Alex Winters; Jeni Gerberich; Li Liu; Ernest Hamel; Ralph P Mason; David J Chaplin; Mary Lynn Trawick; Kevin G Pinney
Journal:  Medchemcomm       Date:  2016-09-22       Impact factor: 3.597

3.  Synthesis of dihydronaphthalene analogues inspired by combretastatin A-4 and their biological evaluation as anticancer agents.

Authors:  Casey J Maguire; Zhi Chen; Vani P Mocharla; Madhavi Sriram; Tracy E Strecker; Ernest Hamel; Heling Zhou; Ramona Lopez; Yifan Wang; Ralph P Mason; David J Chaplin; Mary Lynn Trawick; Kevin G Pinney
Journal:  Medchemcomm       Date:  2018-08-24       Impact factor: 3.597

4.  Design, synthesis, and biological evaluation of water-soluble amino acid prodrug conjugates derived from combretastatin, dihydronaphthalene, and benzosuberene-based parent vascular disrupting agents.

Authors:  Laxman Devkota; Chen-Ming Lin; Tracy E Strecker; Yifan Wang; Justin K Tidmore; Zhi Chen; Rajsekhar Guddneppanavar; Christopher J Jelinek; Ramona Lopez; Li Liu; Ernest Hamel; Ralph P Mason; David J Chaplin; Mary Lynn Trawick; Kevin G Pinney
Journal:  Bioorg Med Chem       Date:  2016-01-06       Impact factor: 3.641

5.  Efficient Synthetic Methodology for the Construction of Dihydronaphthalene and Benzosuberene Molecular Frameworks.

Authors:  Deboprosad Mondal; Haichan Niu; Kevin G Pinney
Journal:  Tetrahedron Lett       Date:  2018-12-16       Impact factor: 2.415

6.  Structure Guided Design, Synthesis, and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin Polymerization.

Authors:  Haichan Niu; Tracy E Strecker; Jeni L Gerberich; James W Campbell; Debabrata Saha; Deboprosad Mondal; Ernest Hamel; David J Chaplin; Ralph P Mason; Mary Lynn Trawick; Kevin G Pinney
Journal:  J Med Chem       Date:  2019-05-24       Impact factor: 7.446

7.  Synthesis of structurally diverse benzosuberene analogues and their biological evaluation as anti-cancer agents.

Authors:  Rajendra P Tanpure; Clinton S George; Tracy E Strecker; Laxman Devkota; Justin K Tidmore; Chen-Ming Lin; Christine A Herdman; Matthew T Macdonough; Madhavi Sriram; David J Chaplin; Mary Lynn Trawick; Kevin G Pinney
Journal:  Bioorg Med Chem       Date:  2013-09-04       Impact factor: 3.641

Review 8.  Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors.

Authors:  Li Liu; Devin O'Kelly; Regan Schuetze; Graham Carlson; Heling Zhou; Mary Lynn Trawick; Kevin G Pinney; Ralph P Mason
Journal:  Molecules       Date:  2021-04-27       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.